Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Russell Brierley Joins Y-PRIME as Product Director, IRT & CSM
  • USA - English


News provided by

Sam Brown

Jun 17, 2014, 10:00 ET

Share this article

Share toX

Share this article

Share toX


Malvern, PA (PRWEB) June 17, 2014 -- Russell Brierley Joins Y-PRIME as Product Director, IRT & CSM

Y-Prime, Inc., a premier eClinical products and consulting company, today announced the appointment of Russell Brierley as Product Director, Interactive Response Technologies (IRT) and Clinical Supply Management (CSM). Brierley will lead the company’s supply chain platforms and activities.

"We continue to invest in bright, forward-thinking innovators who have the clinical research skills and experience needed to help our clients plan and manage clinical trials,” said Shawn Blackburn, Chief Executive Officer, Y-Prime, Inc.

Post this

Brierley is an industry expert with 30 years of experience in clinical supply chain management and drug development and he has served in leadership positions across the spectrum of distribution, packaging, manufacturing and process development/improvement. At Y-Prime Brierley is responsible for continuing the strong growth of the company’s IRT solution and driving market acceptance of the newly introduced eCSF, a Clinical Trial Supply & Forecasting platform – two intuitive and powerful tools that optimize decision-making and productivity as well as cost.

"We continue to invest in bright, forward-thinking innovators who have the clinical research skills and experience needed to help our clients plan and manage clinical trials,” said Shawn Blackburn, Chief Executive Officer, Y-Prime, Inc. “Russell brings deep insights into supply chain management, a critical piece of the clinical development process. His strategic leadership will help our customers manage resources and optimize the quality of their clinical supply chain.”

Prior to joining Y-Prime, Brierley served as Senior Director of North American Clinical Supply Chain, Senior Director of Clinical Development Manufacturing and Director of Biologics Process Development over a 21-year period at Teva, the world’s largest generic drug maker, and at Cephalon prior to its acquisition by Teva in 2011. While there, Brierley was responsible for managing the integrity of the clinical supply chain as well as forecasting and long-range planning in coordination with Clinical Research, Medical Affairs, Chemistry Manufacturing and Controls (CMC), Quality Assurance and Regulatory Affairs. He also designed and directed operations of a 23,000-square-foot cGMP facility for clinical manufacturing, packaging, labeling and distribution of clinical supplies servicing over 1,000 clinical studies. Prior to Cephalon, Brierley was a process development scientist at the Salk Institute Biotechnology Industrial Associates (SIBIA). He started his career in the biotechnology division at The Upjohn Company. Brierley has been an inventor on numerous patents during his tenure in the pharmaceutical industry. He has a bachelor of science degree in biology from the University of Massachusetts Lowell and a Master of Science in biotechnology from Worcester Polytechnic Institute.

“Y-Prime’s eClinical Solutions are best-in-class technologies that can help sponsors and clinical research organizations achieve a high degree of efficiency,” said Brierley. “I look forward to growing our customer base and to further integrating and advancing our IRT and CSM technologies to meet the needs of our clients in an increasingly competitive and complex clinical and regulatory environment.”

IRT & eCSF

Y-Prime’s Interactive Response Technology (IRT) is a cloud-based eClinical platform that solves challenges with patient randomization and clinical supplies management while providing real-time reporting via web and/or telephone user interfaces (IWR and IVR) that are natively integrated with all major Lab, EDC, CTMS and Depot platforms. It is a fluid, fully customizable system that can be rapidly configured to reduce waste and ensure accurate delivery of product while meeting study timelines.

Y-Prime recently introduced eCSF, a Clinical Trial Supply & Forecasting solution that enhances the ability to minimize drug overages, provides a high degree of visibility at the global, depot or individual site level, and allows sponsors to forecast and manage drug supply for clinical trials in real time.

About Y-Prime
Y-Prime, Inc. is the leader in software and technology used in clinical research, healthcare and IT. We help organizations use technology to increase productivity, reduce costs, minimize risk and grow strategically. Better information ... faster. Founded in 2006, Y-Prime is headquartered in Malvern, Pa., and can be found at http://www.y-prime.com. For more information, call 267-620-2000 or email contactus(at)y-prime(dot)com.

Follow us on Google+, Facebook, Twitter, YouTube and LinkedIn.

Contact:
Mike Beyer
Sam Brown Inc.
(312) 961-2502
mikebeyer(at)sambrown(dot)com

Mike Beyer, Sam Brown, http://sambrown.com/, +1 (312) 961-2502, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.